4.2 Review

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies

Journal

RETROVIROLOGY
Volume 15, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12977-018-0434-1

Keywords

HIV-1; bNAbs; Cell-to-cell transmission; Neutralization

Categories

Funding

  1. Institut Pasteur
  2. ANRS
  3. Sidaction
  4. Vaccine Research Institute [ANR-10-LABX-77]
  5. Labex IBEID [ANR-10-IHUB-0002]
  6. TIMTAMDEN [ANR-14-CE14-0029]
  7. CHIKV-Viro-Immuno [ANR-14-CE14-0015-01]
  8. L'Oreal Sponsorhip
  9. Gilead HIV cure program

Ask authors/readers for more resources

HIV-1 spreads through contacts between infected and target cells. Polarized viral budding at the contact site forms the virological synapse. Additional cellular processes, such as nanotubes, filopodia, virus accumulation in endocytic or phagocytic compartments promote efficient viral propagation. Cell-to-cell transmission allows immune evasion and likely contributes to HIV-1 spread in vivo. Anti-HIV-1 broadly neutralizing antibodies (bNAbs) defeat the majority of circulating viral strains by binding to the viral envelope glycoprotein (Env). Several bNAbs have entered clinical evaluation during the last years. It is thus important to understand their mechanism of action and to determine how they interact with infected cells. In experimental models, HIV-1 cell-to-cell transmission is sensitive to neutralization, but the effect of antibodies is often less marked than during cell-free infection. This may be due to differences in the conformation or accessibility of Env at the surface of virions and cells. In this review, we summarize the current knowledge on HIV-1 cell-to-cell transmission and discuss the role of bNAbs during this process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available